4//SEC Filing
INVERNESS MEDICAL INNOVATIONS INC 4
Accession 0001179110-05-020212
CIK 0001145460operating
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 5:13 PM ET
Size
11.9 KB
Accession
0001179110-05-020212
Insider Transaction Report
Form 4
SCOTT DAVID
DirectorChief Technical Officer
Transactions
- Exercise/Conversion
Common Stock
2005-10-13$1.24/sh+5,200$6,448→ 5,200 total - Exercise/Conversion
Common Stock
2005-10-13$0.75/sh+7,800$5,850→ 7,800 total - Exercise/Conversion
Employee Stock Option (right to buy)
2005-10-13−5,200→ 0 totalExercise: $1.24From: 2001-11-20Exp: 2005-10-17→ Common Stock (5,200 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2005-10-13−7,800→ 0 totalExercise: $0.75From: 2001-11-20Exp: 2005-10-17→ Common Stock (7,800 underlying)
Holdings
- 38,173
Common Stock
- 399,381
Common Stock - restricted
Footnotes (2)
- [F1]This derivative security does not have a price.
- [F2]This option was acquired through a restructuring transaction undertaken by the Issuer's former parent, Inverness Medical Technology, Inc., in connection with the consummation of the transactions contemplated by the agreement and plan of split-off and merger dated as of May 23, 2001 among Johnson & Johnson, Sunrise Acquisition Corp. and Inverness Medical Technology, Inc.
Documents
Issuer
INVERNESS MEDICAL INNOVATIONS INC
CIK 0001145460
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001145460
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 5:13 PM ET
- Size
- 11.9 KB